Go Deep
Techno Medica Co., Ltd.
Techno Medica Co., Ltd. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 22,784 | 12.0 | 1.03 | 0.00 | 1,282.77 |
| Oct 2026 | 22,946 | 12.0 | 1.02 | 0.00 | 1,270.04 |
| Oct 2026 | 23,036 | 11.9 | 1.00 | 0.00 | 1,239.97 |
Techno Medica Co., Ltd. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 2,202,353,000.0 | 3,997,793,000.0 | 3,134,406,000.0 | 2,347,305,000.0 |
| Net Profit | 158,993,000.0 | 610,287,000.0 | 257,595,000.0 | 186,625,000.0 |
| EPS | 23.9 | — | — | — |
Techno Medica Co., Ltd. Revenue & Profit: Last 5 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 11,236,606,000.0 | 9,905,864,000.0 | 10,283,851,000.0 | 9,367,586,000.0 | — |
| Net Profit | 1,070,987,000.0 | 1,004,583,000.0 | 1,348,130,000.0 | 1,150,733,000.0 | — |
| EPS | 155.3 | 145.1 | 172.9 | 136.3 | — |
Techno Medica Co., Ltd. Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 17,966,466,000.0 | 17,938,618,000.0 | 17,433,874,000.0 | 19,443,171,000.0 | — |
| Total Liabilities | 3,556,008,000.0 | 3,549,556,000.0 | 3,615,287,000.0 | 3,056,317,000.0 | — |
| Total Equity | 14,410,458,000.0 | 14,389,062,000.0 | 13,818,587,000.0 | 16,386,854,000.0 | — |
Owes vs Owns
Techno Medica Co., Ltd. owed ¥0.16 for every ¥1 it owned in Jun 2026, about the same as ¥0.16 in Mar 2023.
| Period | Jun 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.16× | 0.20× | 0.20× | 0.21× | 0.16× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Techno Medica Co., Ltd. Assets & Liabilities Breakdown (JPY millions)
What it owns — Mar 2026
Cash & short-term investments 50.0%Receivables 19.1%Inventory 12.7%Fixed assets (tangible) 7.5%Other assets 10.4%
How it's funded — Mar 2026
Payables 7.2%Other liabilities 12.6%Shareholders' equity 80.2%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 8,976.2 | 9,061.4 | 8,586.4 | 11,750.3 |
| Receivables | 3,437.1 | 3,315.3 | 3,539.8 | 3,140.7 |
| Inventory | 2,282.3 | 2,607.4 | 2,155.0 | 1,865.5 |
| Fixed assets (tangible) | 1,347.2 | 1,404.1 | 1,448.6 | 1,527.6 |
| Intangible assets | 47.0 | 59.8 | 71.3 | 23.0 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 1,876.6 | 1,490.7 | 1,632.8 | 1,136.1 |
| Liabilities & equity | ||||
| Short-term debt | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term debt | 0.0 | 0.0 | 0.0 | 0.0 |
| Payables | 1,299.4 | 1,575.5 | 1,415.5 | 1,499.6 |
| Other liabilities | 2,256.6 | 1,974.0 | 2,199.8 | 1,556.8 |
| Shareholders' equity | 14,410.5 | 14,389.1 | 13,818.6 | 16,386.9 |
| Net tangible assets | 14,363.4 | 14,329.3 | 13,747.3 | 16,363.9 |
Techno Medica Co., Ltd. Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | 1,100,442,000.0 | 977,535,000.0 | 1,142,703,000.0 | 887,240,000.0 | — |
| Investing Activities | -39,757,000.0 | -32,343,000.0 | -100,716,000.0 | -155,370,000.0 | — |
| Financing Activities | -1,145,845,000.0 | -470,164,000.0 | -4,205,916,000.0 | -505,088,000.0 | — |